{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:40:46Z","timestamp":1793400046474,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004785","name":"Nordforsk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jval.2021.06.001","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T12:39:13Z","timestamp":1628253553000},"page":"1763-1772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cost-Effectiveness of Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study"],"prefix":"10.1016","volume":"24","author":[{"given":"Shuang","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelie","family":"Heintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Miriam","family":"Elfstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Nordstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2021.06.001_bib1","series-title":"Cancer Today. Data Visualization Tools for Exploring the Global Cancer Burden in 2018","year":"2018"},{"issue":"9","key":"10.1016\/j.jval.2021.06.001_bib2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/pros.22979","article-title":"Rapid increase in multidrug-resistant enteric bacilli blood stream infection after prostate biopsy - a 10-year population-based cohort study","volume":"75","author":"Aly","year":"2015","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.jval.2021.06.001_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","article-title":"A\u00a016-yr follow-up of the European Randomized study of Screening for Prostate Cancer","volume":"76","author":"Hugosson","year":"2019","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.jval.2021.06.001_bib4","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/sj.bjc.6605422","article-title":"Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer","volume":"101","author":"Heijnsdijk","year":"2009","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.jval.2021.06.001_bib5","first-page":"366","article-title":"Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data","volume":"107","author":"Heijnsdijk","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.jval.2021.06.001_bib6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1470-2045(13)70442-X","article-title":"Economic burden of cancer across the European Union: a population-based cost analysis","volume":"14","author":"Luengo-Fernandez","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jval.2021.06.001_bib8","series-title":"Oncology Guidelines Prostate Cancer [EAU Guidelines]","year":"2019"},{"issue":"3","key":"10.1016\/j.jval.2021.06.001_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2014.11.037","article-title":"Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis","volume":"68","author":"Schoots","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.jval.2021.06.001_bib10","article-title":"Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer","volume":"4","author":"Drost","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jval.2021.06.001_bib11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2013.12.012","article-title":"Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective","volume":"66","author":"de Rooij","year":"2014","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.jval.2021.06.001_bib12","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2214\/AJR.16.17322","article-title":"Cost-effectiveness comparison of imaging-guided prostate biopsy techniques: systematic transrectal ultrasound, direct in-bore MRI, and image fusion","volume":"208","author":"Venderink","year":"2017","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.jval.2021.06.001_bib13","doi-asserted-by":"crossref","first-page":"119.e1","DOI":"10.1016\/j.urolonc.2015.09.010","article-title":"Cost-effectiveness of multiparametric magnetic resonance imaging and targeted biopsy in diagnosing prostate cancer","volume":"34","author":"Cerantola","year":"2016","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.jval.2021.06.001_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1148\/radiol.2017162181","article-title":"Cost-effectiveness of MR imaging-guided strategies for detection of prostate cancer in biopsy-naive men","volume":"285","author":"Pahwa","year":"2017","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jval.2021.06.001_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.eururo.2017.08.018","article-title":"Optimising the diagnosis of prostate cancer in the era of multiparametric magnetic resonance imaging: a cost-effectiveness analysis based on the Prostate MR Imaging Study (PROMIS)","volume":"73","author":"Faria","year":"2018","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.jval.2021.06.001_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bju.14151","article-title":"Cost-effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer","volume":"122","author":"Barnett","year":"2018","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.jval.2021.06.001_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211918","article-title":"A\u00a0natural history model for planning prostate cancer testing: calibration and validation using Swedish registry data","volume":"14","author":"Karlsson","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jval.2021.06.001_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eururo.2012.10.001","article-title":"Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, despite no recommendations for PSA screening: results from a population-based study, 2003-2011","volume":"63","author":"Nordstr\u00f6m","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.jval.2021.06.001_bib19","unstructured":"Tandv\u00e5rds- och L\u00e4kemedelsf\u00f6rm\u00e5nsverket. Tandv\u00e5rds- och L\u00e4kemedelsf\u00f6rm\u00e5nsverkets Allm\u00e4nna R\u00e5d. TLVAR 2017:1 \u00c4ndring i Tandv\u00e5rds- och L\u00e4kemedelsf\u00f6rm\u00e5nsverkets Allm\u00e4nna r\u00e5d (TLVAR 2003:2) om Ekonomiska Utv\u00e4rderingar. Stockholm."},{"key":"10.1016\/j.jval.2021.06.001_bib20","article-title":"Cost effectiveness and strategic planning (WHO-CHOICE)","year":"2020","journal-title":"Health State Valuations"},{"issue":"1","key":"10.1016\/j.jval.2021.06.001_bib21","article-title":"A\u00a0systematic review and meta-analysis of prostate cancer utility values of patients and partners between 2007 and 2016","volume":"4","author":"Magnus","year":"2019","journal-title":"MDM Policy Pract"},{"issue":"20","key":"10.1016\/j.jval.2021.06.001_bib23","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1002\/cam4.3395","article-title":"Assessment of harms, benefits, and cost-effectiveness of prostate cancer screening: a micro-simulation study of 230 scenarios","volume":"9","author":"Getaneh","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.jval.2021.06.001_bib24","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"issue":"1","key":"10.1016\/j.jval.2021.06.001_bib26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/s12913-020-05265-8","article-title":"The economic burden of prostate cancer - a Swedish prevalence-based register study","volume":"20","author":"Hao","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jval.2021.06.001_bib27","article-title":"Fixed index numbers (1980=100)","year":"2019","journal-title":"Statistikmyndigheten"},{"key":"10.1016\/j.jval.2021.06.001_bib28","series-title":"Exchange Rates (Indicator)","year":"2020"},{"key":"10.1016\/j.jval.2021.06.001_bib29","article-title":"Cost effectiveness and strategic planning (WHO-CHOICE)","year":"2020","journal-title":"Eur Reg"},{"issue":"7","key":"10.1016\/j.jval.2021.06.001_bib30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa1201637","article-title":"Quality-of-life effects of prostate-specific antigen screening","volume":"367","author":"Heijnsdijk","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jval.2021.06.001_bib31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/0272989X10396717","article-title":"How does early detection by screening affect disease progression? Modeling estimated benefits in prostate cancer screening","volume":"31","author":"Wever","year":"2011","journal-title":"Med Decis Making"},{"issue":"4","key":"10.1016\/j.jval.2021.06.001_bib32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/ijc.28732","article-title":"Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada","volume":"135","author":"Pataky","year":"2014","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.jval.2021.06.001_bib33","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s40273-015-0307-6","article-title":"Reimbursement decisions for pharmaceuticals in Sweden: the impact of disease severity and cost effectiveness","volume":"33","author":"Svensson","year":"2015","journal-title":"Pharmacoeconomics"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301521015874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301521015874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:24:03Z","timestamp":1761096243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301521015874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1098301521015874"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2021.06.001","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2021.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}